Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human/Mouse EphA5 Antibody, R&D Systems™

Goat Polyclonal Antibody
Supplier: R&D Systems AF3037
This item is not returnable.
View return policy
Description
EphA5 Polyclonal specifically detects EphA5 in Human, Mouse samples. It is validated for Western Blot, Flow Cytometry, CyTOF-ready.Specifications
EphA5 | |
Polyclonal | |
Unconjugated | |
Q60629 | |
EPHA5 | |
Mouse myeloma cell line NS0-derived recombinant mouse EphA5 Ser58-Pro412 Accession # Q60629 | |
100 μg | |
Primary | |
Detects mouse EphA5 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 15% cross-reactivity with recombinant mouse (rm) EphA3 is observed, 10% cross-reactivity with rmEphA7 is observed, 5% cross-reactivity with rmEphA2, rmEphA4, rmEphA8, rmEphB2, rmEphB3, and recombinant rat EphB1 is observed, and less than 1% cross-reactivity with rmEphA1, rmEphB4, and rmEphB6 is observed. | |
Human, Mouse | |
IgG |
Western Blot, Flow Cytometry, CyTOF | |
LYOPH | |
Western Blot 0.1 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready | |
Bsk, Cek7, EC 2.7.10, EC 2.7.10.1, Ehk1, EHK-1, EHK1Hek7, EK7, EPH homology kinase 1, Eph homology kinase-1, EPH receptor A5, EphA5, EPH-like kinase 7, ephrin type-A receptor 5, hEK7, receptor protein-tyrosine kinase HEK7, Rek7, TYRO4HEK7CEK7, tyrosine-protein kinase receptor EHK-1 | |
Goat | |
Affinity Purified | |
RUO | |
2044 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction